Hutchison C - Search Results

1

Evolving strategies in the diagnosis, treatment, and monitoring of myeloma kidney.

Hutchison C, Sanders PW. Hutchison C, et al. Adv Chronic Kidney Dis. 2012 Sep;19(5):279-81. doi: 10.1053/j.ackd.2012.07.004. Adv Chronic Kidney Dis. 2012. PMID: 22920636 No abstract available.

2

The pathogenesis and diagnosis of acute kidney injury in multiple myeloma.

Hutchison CA, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A, Herrera GA, Lachmann H, Sanders PW; International Kidney and Monoclonal Gammopathy Research Group. Hutchison CA, et al. Nat Rev Nephrol. 2011 Nov 1;8(1):43-51. doi: 10.1038/nrneph.2011.168. Nat Rev Nephrol. 2011. PMID: 22045243 Free PMC article. Review.

3

High cut-off dialysis membranes: current uses and future potential.

Gondouin B, Hutchison CA. Gondouin B, et al. Adv Chronic Kidney Dis. 2011 May;18(3):180-7. doi: 10.1053/j.ackd.2011.02.006. Adv Chronic Kidney Dis. 2011. PMID: 21531324 Review.

4

Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.

Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D. Hutchison CA, et al. Nephrol Dial Transplant. 2012 Oct;27(10):3823-8. doi: 10.1093/ndt/gfr773. Epub 2012 Jan 23. Nephrol Dial Transplant. 2012. PMID: 22273664

5

Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.

Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S, Hutchison CA, Cook M, Stoves J, Bradwell AR, Cockwell P. Basnayake K, et al. J Clin Pathol. 2010 Oct;63(10):884-7. doi: 10.1136/jcp.2010.079236. J Clin Pathol. 2010. PMID: 20876319

6

Novel approaches for reducing free light chains in patients with myeloma kidney.

Hutchison CA, Bladé J, Cockwell P, Cook M, Drayson M, Fermand JP, Kastritis E, Kyle R, Leung N, Pasquali S, Winearls C; International Kidney and Monoclonal Gammopathy Research Group. Hutchison CA, et al. Nat Rev Nephrol. 2012 Feb 21;8(4):234-43. doi: 10.1038/nrneph.2012.14. Nat Rev Nephrol. 2012. PMID: 22349488 Review.

7

Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.

Yadav P, Hutchison CA, Basnayake K, Stringer S, Jesky M, Fifer L, Snell K, Pinney J, Drayson MT, Cook M, Cockwell P. Yadav P, et al. Eur J Haematol. 2016 Jun;96(6):610-7. doi: 10.1111/ejh.12644. Epub 2015 Sep 16. Eur J Haematol. 2016. PMID: 26248588

8

The treatment of paraprotein-related kidney disease.

Hutchison CA, Xiong F, Mollee P. Hutchison CA, et al. Curr Opin Nephrol Hypertens. 2017 Nov;26(6):477-483. doi: 10.1097/MNH.0000000000000369. Curr Opin Nephrol Hypertens. 2017. PMID: 28885307 Review.

9

Monoclonal gammopathy of undetermined significance: an update for nephrologists.

Parry HM, Pratt G, Hutchison CA. Parry HM, et al. Among authors: hutchison ca. Adv Chronic Kidney Dis. 2012 Sep;19(5):291-6. doi: 10.1053/j.ackd.2012.07.006. Adv Chronic Kidney Dis. 2012. PMID: 22920639 Review.

10

Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney.

Grima DT, Airia P, Attard C, Hutchison CA. Grima DT, et al. Among authors: hutchison ca. Curr Med Res Opin. 2011 Feb;27(2):383-91. doi: 10.1185/03007995.2010.543125. Epub 2010 Dec 23. Curr Med Res Opin. 2011. PMID: 21175375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

511 results

Search Page